hVIVO conduct research using the Human Challenge Model. The Human Challenge Model is a study during which healthy volunteers are deliberately exposed to a virus, known as the “challenge virus”. This is different to standard vaccine clinical trials where volunteers are exposed to viruses naturally. The Human Challenge Model can provide a more efficient and faster way to develop vaccines as fewer volunteers are required.
hVIVO have completed 50 research projects which have included over 3,000 volunteers, using viruses such as Influenza, Respiratory Syncytial Virus (RSV) and Human Rhinovirus (HRV). We are exploring using this model to help development of COVID-19 specific vaccines and treatments.
The Human Challenge Model is used to develop vaccines and treatments across multiple diseases including malaria, typhoid, norovirus, common cold and Influenza. Our model has been established and used safely over many years.Register Now
By registering your details you will added to the hVIVO recruitment database.